Febbo Phillip G. 4
4 · VERACYTE, INC. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Award
Common Stock
2023-10-02+53,182→ 53,182 total - Award
Stock Option (right to buy)
2023-10-02+85,858→ 85,858 totalExercise: $21.96Exp: 2033-10-02→ Common Stock (85,858 underlying)
Footnotes (2)
- [F1]Restricted stock units awarded on October 2, 2023 vest 25% on December 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- [F2]The option becomes exercisable as to 25% of the shares on October 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.